Ask what Korea is talking about.

Starting Nov. 12, South Korea will allow individuals to bring in up to three months' supply of prescription obesity drugs purchased overseas, including popular treatments like Wegovy and Mounjaro, the Ministry of Food and Drug Safety and the Korea Customs Service announced Wednesday. Previously, even legally prescribed overseas medications could not be brought into the country, but the new rule permits personal carry-on import for self-treatment, with up to 12 units of Japan's Mounjaro, nicknamed 'sushi jaro,' allowed. The Korea Times reports the ministry also issued a safety alert over a rare vision-loss risk linked to GLP-1 obesity drugs. Korean media, including Chosun Ilbo and Kyunghyang Shinmun, highlight the move as opening a previously blocked channel, noting the drugs are cheaper abroad and have gained popularity.